Innovative Antiviral Therapies
The programme area Innovative Antiviral Therapies focuses on translational research. The aim is to identify new approaches for the development of antiviral agents and tumour therapy.
The Innovative Antiviral Therapies program area focuses on translational research to validate antiviral targets and experimental therapies. The Next Generation Sequencing and Small Animal Models technology platforms support the in vitro and in vivo evaluation of new antiviral therapies.
Kontakt
Head of Program Area
Phone: +49 (0)40 48051-221
Email: Please enable JavaScript to render this link!